Free Trial

Bruker (BRKR) Competitors

Bruker logo
$39.00 -0.71 (-1.79%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$39.72 +0.72 (+1.85%)
As of 10/24/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BRKR vs. TECH, A, DHR, IQV, MTD, RVTY, TMO, WAT, ILMN, and CRL

Should you be buying Bruker stock or one of its competitors? The main competitors of Bruker include Bio-Techne (TECH), Agilent Technologies (A), Danaher (DHR), IQVIA (IQV), Mettler-Toledo International (MTD), Revvity (RVTY), Thermo Fisher Scientific (TMO), Waters (WAT), Illumina (ILMN), and Charles River Laboratories International (CRL).

Bruker vs. Its Competitors

Bruker (NASDAQ:BRKR) and Bio-Techne (NASDAQ:TECH) are both life sciences tools & services companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability.

Bruker presently has a consensus price target of $51.00, suggesting a potential upside of 30.77%. Bio-Techne has a consensus price target of $70.58, suggesting a potential upside of 7.11%. Given Bruker's higher probable upside, equities analysts plainly believe Bruker is more favorable than Bio-Techne.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bruker
1 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.36
Bio-Techne
1 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.63

Bruker has higher revenue and earnings than Bio-Techne. Bruker is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bruker$3.44B1.72$113.10M$0.5275.00
Bio-Techne$1.22B8.41$73.40M$0.46143.26

In the previous week, Bruker had 12 more articles in the media than Bio-Techne. MarketBeat recorded 25 mentions for Bruker and 13 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 1.04 beat Bruker's score of 0.18 indicating that Bio-Techne is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bruker
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Bio-Techne
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.5%. Bio-Techne pays an annual dividend of $0.32 per share and has a dividend yield of 0.5%. Bruker pays out 38.5% of its earnings in the form of a dividend. Bio-Techne pays out 69.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bruker is clearly the better dividend stock, given its higher yield and lower payout ratio.

Bruker has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500. Comparatively, Bio-Techne has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500.

Bio-Techne has a net margin of 6.02% compared to Bruker's net margin of 2.31%. Bruker's return on equity of 17.89% beat Bio-Techne's return on equity.

Company Net Margins Return on Equity Return on Assets
Bruker2.31% 17.89% 5.38%
Bio-Techne 6.02%13.43%10.32%

79.5% of Bruker shares are owned by institutional investors. Comparatively, 98.9% of Bio-Techne shares are owned by institutional investors. 27.3% of Bruker shares are owned by company insiders. Comparatively, 1.3% of Bio-Techne shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Bio-Techne beats Bruker on 10 of the 19 factors compared between the two stocks.

Get Bruker News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BRKR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BRKR vs. The Competition

MetricBrukerINSTRU IndustryComputer SectorNASDAQ Exchange
Market Cap$6.02B$1.04B$33.06B$10.66B
Dividend Yield0.51%0.51%3.18%4.82%
P/E Ratio75.0028.66103.6930.21
Price / Sales1.721.101,288.56132.63
Price / Cash11.0619.1838.0861.44
Price / Book3.292.217.576.60
Net Income$113.10M$17.67M$820.47M$276.82M
7 Day Performance5.46%3.57%2.51%2.58%
1 Month Performance26.71%3.62%3.69%3.76%
1 Year Performance-32.64%-14.07%24,146.19%33.84%

Bruker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BRKR
Bruker
4.9082 of 5 stars
$39.00
-1.8%
$51.00
+30.8%
-33.2%$6.02B$3.44B75.0011,396News Coverage
Analyst Forecast
Analyst Revision
Gap Up
TECH
Bio-Techne
4.3889 of 5 stars
$62.54
+1.1%
$70.58
+12.9%
-3.6%$9.63B$1.22B135.963,100Positive News
Analyst Forecast
A
Agilent Technologies
3.8042 of 5 stars
$143.03
+0.8%
$149.62
+4.6%
+13.2%$40.23B$6.51B33.5817,900Positive News
Analyst Forecast
DHR
Danaher
4.8237 of 5 stars
$208.06
-0.5%
$245.00
+17.8%
-10.0%$149.70B$23.88B44.2763,000Trending News
Earnings Report
Analyst Forecast
Analyst Revision
IQV
IQVIA
4.3877 of 5 stars
$212.30
+3.8%
$234.57
+10.5%
+4.2%$34.77B$15.41B30.7288,000Upcoming Earnings
MTD
Mettler-Toledo International
4.1004 of 5 stars
$1,358.53
+0.7%
$1,336.50
-1.6%
+11.0%$27.79B$3.87B34.4017,300News Coverage
Positive News
RVTY
Revvity
2.8093 of 5 stars
$95.33
+2.0%
$116.62
+22.3%
-14.9%$10.84B$2.76B19.1011,000News Coverage
Upcoming Earnings
Dividend Announcement
Analyst Forecast
TMO
Thermo Fisher Scientific
4.6543 of 5 stars
$544.02
+0.9%
$589.10
+8.3%
+2.8%$203.50B$42.88B24.62125,000Trending News
Earnings Report
Analyst Forecast
Analyst Revision
WAT
Waters
4.1269 of 5 stars
$343.16
+2.6%
$376.80
+9.8%
+9.6%$19.92B$2.96B30.947,600Trending News
Analyst Forecast
ILMN
Illumina
4.6917 of 5 stars
$99.50
+4.2%
$115.25
+15.8%
-29.2%$14.67B$4.37B12.599,030Upcoming Earnings
Analyst Forecast
CRL
Charles River Laboratories International
4.3069 of 5 stars
$184.10
+3.1%
$181.29
-1.5%
+8.1%$8.79B$4.05B-138.4220,100Analyst Downgrade

Related Companies and Tools


This page (NASDAQ:BRKR) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners